Data as of Q4 2025 (Dec 31, 2025)

Trails Edge Capital Partners, LP

โ€ขCIK: 2077247โ€ขFiling: Q4 2025

**Trails Edge Capital Partners, LP** manages $405M across a focused portfolio of 23 positions. The fund exhibits significant concentration in select names, with top holdings including ACAD at $37.9M and BRD1EUR at $34.4M. Further substantial allocations are noted in PCVX ($34.0M), NRIX ($33.1M), and LBRX ($31.1M). This structure suggests a conviction-driven, concentrated approach targeting high-conviction opportunities.

Total AUM
$404.7M
QoQ Performance
N/A
Positions
23
Top 10 Concentration
68.5%
Latest Filing
Q4 2025

Top Holdings Allocation

ACAD
BRD1EUR
PCVX
NRIX
LBRX
XENE
IMCR
RCUS
ACAD9.4%
BRD1EUR8.5%
PCVX8.4%
NRIX8.2%
LBRX7.7%
XENE6.6%
IMCR5.9%
RCUS5.4%

๐Ÿ“ˆ Biggest Buys

ACAD
ACADIA PHARMACEUTICALS INC
NEW
9.4% of portfolio
BRD1EUR
MIND MEDICINE MINDMED INC
NEW
8.5% of portfolio
PCVX
VAXCYTE INC
NEW
8.4% of portfolio
NRIX
NURIX THERAPEUTICS INC
NEW
8.2% of portfolio
LBRX
LB PHARMACEUTICALS INC
NEW
7.7% of portfolio

๐Ÿ“‰ Biggest Sells

No reductions this quarter

Sector Breakdown

Other100.0%

Changes from Q2 2025

NEW23 new positions

Historical Filings

Q4 2025Q2 2025